Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: REVVITY HEALTH SCIENCES, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2018-09-07 to 2023-09-30
Current total value of award: $33278
Description: PURCHASE OF VASOPRESSIN (TAMC), NON-NOVATION NAME CHANGE FROM PERKINELMER HEALTH SCIENCES, INC. TO REVVITY HEALTH SCIENCES, INC.